Home » Topics » Regulatory » Patents

Patents
RSS

Enanta patents novel farnesoid X receptor agonists

Dec. 1, 2017

Novel AMP-activated protein kinase activators generated at Shionogi

Dec. 1, 2017

Luoda Biosciences and Nanjing Shiqi Pharmaceutical describe novel anticancer compounds

Dec. 1, 2017

Zhejiang Hisun Pharmaceutical presents new epothilone derivatives

Dec. 1, 2017

Istituto Europeo di Oncologia Srl synthesizes new lysine-specific demethylase 4C inhiibitors

Nov. 30, 2017

Novel soluble guanylate cyclase activators discovered at Merck & Co.

Nov. 30, 2017

Lilly identifies novel beta-secretase 1 inhibitors

Nov. 30, 2017

Idorsia Pharmaceuticals patents novel antibacterials

Nov. 30, 2017

Cambridge Enterprise, Sydney Children's Hospitals Network design viral vectors encoding factor I

Nov. 30, 2017

Novel Staphylococcus epidermidis autoinducing peptide analogues discovered at WARF

Nov. 29, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...